These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 28899579

  • 1. CXCL4-induced macrophages in human atherosclerosis.
    Domschke G, Gleissner CA.
    Cytokine; 2019 Oct; 122():154141. PubMed ID: 28899579
    [Abstract] [Full Text] [Related]

  • 2. CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages.
    Gleissner CA, Shaked I, Erbel C, Böckler D, Katus HA, Ley K.
    Circ Res; 2010 Jan 08; 106(1):203-11. PubMed ID: 19910578
    [Abstract] [Full Text] [Related]

  • 3. CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+ in vitro and in vivo.
    Erbel C, Tyka M, Helmes CM, Akhavanpoor M, Rupp G, Domschke G, Linden F, Wolf A, Doesch A, Lasitschka F, Katus HA, Gleissner CA.
    Innate Immun; 2015 Apr 08; 21(3):255-65. PubMed ID: 24663337
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of M4 macrophages within human coronary atherosclerotic plaques is associated with features of plaque instability.
    Erbel C, Wolf A, Lasitschka F, Linden F, Domschke G, Akhavanpoor M, Doesch AO, Katus HA, Gleissner CA.
    Int J Cardiol; 2015 Apr 08; 186():219-25. PubMed ID: 25828120
    [Abstract] [Full Text] [Related]

  • 5. Platelet-derived chemokines in atherogenesis: what's new?
    Gleissner CA.
    Curr Vasc Pharmacol; 2012 Sep 08; 10(5):563-9. PubMed ID: 22338571
    [Abstract] [Full Text] [Related]

  • 6. Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis.
    Gleissner CA.
    Front Physiol; 2012 Sep 08; 3():1. PubMed ID: 22275902
    [Abstract] [Full Text] [Related]

  • 7. Platelet-derived chemokines in inflammation and atherosclerosis.
    Bakogiannis C, Sachse M, Stamatelopoulos K, Stellos K.
    Cytokine; 2019 Oct 08; 122():154157. PubMed ID: 29198385
    [Abstract] [Full Text] [Related]

  • 8. CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages.
    Gleissner CA, Shaked I, Little KM, Ley K.
    J Immunol; 2010 May 01; 184(9):4810-8. PubMed ID: 20335529
    [Abstract] [Full Text] [Related]

  • 9. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.
    Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K.
    Nat Med; 2003 Jan 01; 9(1):61-7. PubMed ID: 12483207
    [Abstract] [Full Text] [Related]

  • 10. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice.
    Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A, Kramp BK, Piccinini AM, Paludan SR, Kowalska MA, Kungl AJ, Hackeng TM, Mayo KH, Weber C.
    Nat Med; 2009 Jan 01; 15(1):97-103. PubMed ID: 19122657
    [Abstract] [Full Text] [Related]

  • 11. Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7.
    Chatterjee M, von Ungern-Sternberg SN, Seizer P, Schlegel F, Büttcher M, Sindhu NA, Müller S, Mack A, Gawaz M.
    Cell Death Dis; 2015 Nov 19; 6(11):e1989. PubMed ID: 26583329
    [Abstract] [Full Text] [Related]

  • 12. Changes in transcriptome of macrophages in atherosclerosis.
    Chistiakov DA, Bobryshev YV, Orekhov AN.
    J Cell Mol Med; 2015 Jun 19; 19(6):1163-73. PubMed ID: 25973901
    [Abstract] [Full Text] [Related]

  • 13. Endothelial cell-borne platelet bridges selectively recruit monocytes in human and mouse models of vascular inflammation.
    Kuckleburg CJ, Yates CM, Kalia N, Zhao Y, Nash GB, Watson SP, Rainger GE.
    Cardiovasc Res; 2011 Jul 01; 91(1):134-41. PubMed ID: 21285294
    [Abstract] [Full Text] [Related]

  • 14. Monocyte Recruitment, Specification, and Function in Atherosclerosis.
    Kim KW, Ivanov S, Williams JW.
    Cells; 2020 Dec 24; 10(1):. PubMed ID: 33374145
    [Abstract] [Full Text] [Related]

  • 15. CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis.
    Gouwy M, Ruytinx P, Radice E, Claudi F, Van Raemdonck K, Bonecchi R, Locati M, Struyf S.
    PLoS One; 2016 Dec 24; 11(11):e0166006. PubMed ID: 27828999
    [Abstract] [Full Text] [Related]

  • 16. CXC chemokine ligand 4 (CXCL4) down-regulates CC chemokine receptor expression on human monocytes.
    Schwartzkopff F, Petersen F, Grimm TA, Brandt E.
    Innate Immun; 2012 Feb 24; 18(1):124-39. PubMed ID: 21088050
    [Abstract] [Full Text] [Related]

  • 17. Pathophysiological relevance of macrophage subsets in atherogenesis.
    Liberale L, Dallegri F, Montecucco F, Carbone F.
    Thromb Haemost; 2017 Jan 05; 117(1):7-18. PubMed ID: 27683760
    [Abstract] [Full Text] [Related]

  • 18. Platelet-derived MIF: a novel platelet chemokine with distinct recruitment properties.
    Wirtz TH, Tillmann S, Strüßmann T, Kraemer S, Heemskerk JW, Grottke O, Gawaz M, von Hundelshausen P, Bernhagen J.
    Atherosclerosis; 2015 Mar 05; 239(1):1-10. PubMed ID: 25561410
    [Abstract] [Full Text] [Related]

  • 19. Platelet factor 4 (CXCL4) facilitates human macrophage infection with HIV-1 and potentiates virus replication.
    Schwartzkopff F, Grimm TA, Lankford CS, Fields K, Wang J, Brandt E, Clouse KA.
    Innate Immun; 2009 Dec 05; 15(6):368-79. PubMed ID: 19773294
    [Abstract] [Full Text] [Related]

  • 20. Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13.
    Halvorsen B, Smedbakken LM, Michelsen AE, Skjelland M, Bjerkeli V, Sagen EL, Taskén K, Bendz B, Gullestad L, Holm S, Biessen EA, Aukrust P.
    Atherosclerosis; 2014 Jun 05; 234(2):352-9. PubMed ID: 24732574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.